Screener
Pulse Biosciences, Inc. PLSE Business Segments — Segment Reporting Other Item Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cross platform research and engineering2 | 6,078 | 4,585 | 11,258 | 8,535 |
| R&D manufacturing and engineering3 | 3,201 | 2,941 | 5,550 | 4,736 |
| Clinical and regulatory4 | 5,127 | 2,183 | 8,387 | 3,943 |
| General and administrative5 | 4,548 | 2,742 | 8,490 | 5,461 |
| Sales and marketing6 | 1,279 | 2,362 | 3,607 | 4,218 |
| Other segment items7 | 5,228 | 5,462 | 7,394 | 11,426 |
| Total other income, net | (615) | (1,107) | (1,184) | (2,356) |
| Net loss | $(24,657) | $(19,168) | $(43,238) | $(35,963) |
Document
FAQ
- What is Pulse Biosciences, Inc.'s business segments — segment reporting other item amount?
- Pulse Biosciences, Inc. (PLSE) reported business segments — segment reporting other item amount of $5.23M in Q2 2026.
- What does business segments — segment reporting other item amount mean?
- This captures miscellaneous or non-recurring items that do not fit into standard operating expense categories. It is used to reconcile segment-specific performance by accounting for unique or infrequent financial events.
Ask your AI about Pulse Biosciences, Inc.'s business segments — segment reporting other item amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude